Business News • MarketWire • Vicor Technologies Receives Allowance of United States Patent Application Related to Its State Dependent Drug Development Platform

Vicor Technologies Receives Allowance of United States Patent Application Related to Its State Dependent Drug Development Platform

Vicor Technologies Receives Allowance of United States Patent Application Related to Its State Dependent Drug Development Platform

BOCA RATON, FL--(Marketwire - May 4, 2010) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced the Company received a Notice of Allowance for its U.S. Patent Application No. 10/359,363 for a method of treating ischemia through administration of a biologic identified through Vicor's state dependent drug discovery platform. Upon issuance, this patent will provide Vicor with patent protection for methods of using a peptide to treat infarctions, such as cardiac or cerebral infarctions.

View More : http://www.marketwire.com/mw/release.do?id=1158321&sourceType=3

Releted News by marketwire

Trade Alert: China America Holdings -- May 4, 2010

Dov Schwell and Pierre Leignadier Elected to Board of Directors of WindTamer Corporation